SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-22-060382
Filing Date
2022-03-01
Accepted
2022-03-01 11:02:00
Documents
7

Document Format Files

Seq Description Document Type Size
1 POS AM d660970dposam.htm POS AM 362026
2 EX-5.1 d660970dex51.htm EX-5.1 30364
3 EX-23.2 d660970dex232.htm EX-23.2 1589
4 GRAPHIC g660970g0226211141325.jpg GRAPHIC 2345
5 GRAPHIC g660970g0226211141700.jpg GRAPHIC 1769
6 GRAPHIC g660970g04a00.jpg GRAPHIC 36552
7 GRAPHIC g660970g34a57.jpg GRAPHIC 40879
  Complete submission text file 0001193125-22-060382.txt   499364
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-244401 | Film No.: 22695148
SIC: 2834 Pharmaceutical Preparations